We constructed a predictive model based on the level of both CEA and CYFRA21‐1 to evaluate the utility of plasma samples to diagnose genetic alterations of advanced lung cancer based on the high concordance or discordance of plasma and tumor biopsies. This evidence concerns the gene CEACAM5 and lung cancer.